Kjetil Boye

5.8k total citations
84 papers, 2.2k citations indexed

About

Kjetil Boye is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Kjetil Boye has authored 84 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 23 papers in Molecular Biology. Recurrent topics in Kjetil Boye's work include Sarcoma Diagnosis and Treatment (28 papers), Gastrointestinal Tumor Research and Treatment (21 papers) and Gastric Cancer Management and Outcomes (16 papers). Kjetil Boye is often cited by papers focused on Sarcoma Diagnosis and Treatment (28 papers), Gastrointestinal Tumor Research and Treatment (21 papers) and Gastric Cancer Management and Outcomes (16 papers). Kjetil Boye collaborates with scholars based in Norway, Sweden and Netherlands. Kjetil Boye's co-authors include Gunhild M. Mælandsmo, Kjersti Flatmark, Øystein Fodstad, Bodil Bjerkehagen, Jahn M. Nesland, Kristina Schee, Torveig Weum Abrahamsen, Kirsten Sundby Hall, Stephan Stoldt and Toto Hølmebakk and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kjetil Boye

80 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kjetil Boye Norway 25 1.0k 678 636 587 431 84 2.2k
An Na Seo South Korea 27 803 0.8× 1.4k 2.1× 681 1.1× 555 0.9× 417 1.0× 107 2.5k
Hsuan-Ying Huang Taiwan 30 1.2k 1.1× 700 1.0× 822 1.3× 434 0.7× 95 0.2× 55 2.4k
Lorena Incorvaia Italy 24 602 0.6× 910 1.3× 675 1.1× 481 0.8× 247 0.6× 113 1.9k
Brian P. Adley United States 22 724 0.7× 347 0.5× 405 0.6× 313 0.5× 149 0.3× 30 1.5k
Jia-Lin Lee South Korea 21 919 0.9× 892 1.3× 503 0.8× 344 0.6× 146 0.3× 50 2.0k
Marco Pizzi Italy 28 910 0.9× 463 0.7× 385 0.6× 629 1.1× 330 0.8× 124 2.2k
Yuji Sakuma Japan 26 698 0.7× 589 0.9× 1.2k 1.9× 331 0.6× 136 0.3× 90 2.3k
Thomas A. Puchalski United States 24 905 0.9× 1.5k 2.3× 834 1.3× 413 0.7× 789 1.8× 51 2.8k
Hee Eun Lee South Korea 29 1.0k 1.0× 1.3k 2.0× 707 1.1× 680 1.2× 142 0.3× 86 2.7k
Laura Boldrini Italy 27 1.2k 1.1× 916 1.4× 733 1.2× 652 1.1× 167 0.4× 98 2.5k

Countries citing papers authored by Kjetil Boye

Since Specialization
Citations

This map shows the geographic impact of Kjetil Boye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kjetil Boye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kjetil Boye more than expected).

Fields of papers citing papers by Kjetil Boye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kjetil Boye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kjetil Boye. The network helps show where Kjetil Boye may publish in the future.

Co-authorship network of co-authors of Kjetil Boye

This figure shows the co-authorship network connecting the top 25 collaborators of Kjetil Boye. A scholar is included among the top collaborators of Kjetil Boye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kjetil Boye. Kjetil Boye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Connolly, Elizabeth A., Kjetil Boye, Sylvie Bonvalot, et al.. (2025). Genetic predisposition in sarcomas: clinical implications and management. EClinicalMedicine. 83. 103203–103203.
2.
Yip, Desmond, John Zalcberg, Jean‐Yves Blay, et al.. (2025). Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial. British Journal of Cancer. 132(10). 897–904. 1 indexed citations
3.
Zhou, Yang, Partho Sarothi Ray, Jianguo Zhu, et al.. (2024). Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma. Nature Communications. 15(1). 2810–2810. 5 indexed citations
4.
Spałek, Mateusz, Kjetil Boye, Anna Szumera‐Ciećkiewicz, et al.. (2023). Diagnostics and Treatment of Extrameningeal Solitary Fibrous Tumors. Cancers. 15(24). 5854–5854. 7 indexed citations
5.
Namløs, Heidi M., Sigve Nakken, Daniel Vodák, et al.. (2023). Chromosomal instability and a deregulated cell cycle are intrinsic features of high‐risk gastrointestinal stromal tumours with a metastatic potential. Molecular Oncology. 17(11). 2432–2450. 1 indexed citations
6.
Hølmebakk, Toto, Florian Puls, Stephan Stoldt, et al.. (2023). Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy. British journal of surgery. 110(12). 1857–1862. 4 indexed citations
7.
Öfverholm, Ingegerd, et al.. (2023). Sarcoma care in the era of precision medicine. Journal of Internal Medicine. 294(6). 690–707. 13 indexed citations
8.
Namløs, Heidi M., Nitin Sharma, Susanne Lorenz, et al.. (2021). Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour. Pathology. 53(6). 713–719. 35 indexed citations
9.
Hølmebakk, Toto, Leonardo A. Meza‐Zepeda, Ivar Hompland, et al.. (2021). Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach. Annals of Surgical Oncology. 28(11). 6837–6845. 13 indexed citations
10.
Namløs, Heidi M., Kjetil Boye, Tale Barøy, et al.. (2018). Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics. 17(11). 2473–2480. 60 indexed citations
11.
Namløs, Heidi M., Olga Zaikova, Bodil Bjerkehagen, et al.. (2017). Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report. BMC Cancer. 17(1). 29–29. 23 indexed citations
12.
Thorgersen, Ebbe Billmann, Mariusz Adam Goscinski, Milan Spasojevic, et al.. (2016). Deep Pelvic Surgical Site Infection After Radiotherapy and Surgery for Locally Advanced Rectal Cancer. Annals of Surgical Oncology. 24(3). 721–728. 10 indexed citations
13.
Prasmickaite, Lina, G Berge, Steinar Aamdal, et al.. (2015). Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial. Cancer Immunology Immunotherapy. 64(6). 769–776. 5 indexed citations
14.
Panagopoulos, Ioannis, Ludmila Gorunova, Bodil Bjerkehagen, Kjetil Boye, & Sverre Heim. (2014). Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma. Oncology Reports. 32(1). 40–44. 40 indexed citations
15.
Friedman, Ran, Kjetil Boye, & Kjersti Flatmark. (2013). Molecular modelling and simulations in cancer research. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1836(1). 1–14. 47 indexed citations
16.
Lund‐Iversen, Marius, G Berge, Odd Terje Brustugun, et al.. (2012). Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer. BMC Cancer. 12(1). 333–333. 16 indexed citations
17.
Boye, Kjetil, et al.. (2012). B7‐H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer. International Journal of Cancer. 131(11). 2528–2536. 104 indexed citations
18.
Boye, Kjetil, Jahn M. Nesland, Berit Sandstad, Gunhild M. Mælandsmo, & Kjersti Flatmark. (2010). Nuclear S100A4 is a novel prognostic marker in colorectal cancer. European Journal of Cancer. 46(16). 2919–2925. 40 indexed citations
19.
Andersen, Karin, Birgitte Smith‐Sørensen, Kjetil Boye, et al.. (2003). Interferon-γ suppresses S100A4 transcription independently of apoptosis or cell cycle arrest. British Journal of Cancer. 88(12). 1995–2001. 17 indexed citations
20.
Boye, Kjetil, et al.. (2002). Expression of S100A4, E-cadherin, α- and β-catenin in breast cancer biopsies. British Journal of Cancer. 87(11). 1281–1286. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by An Na Seo Breakdown of academic impact, for papers by Hsuan-Ying Huang Breakdown of academic impact, for papers by Lorena Incorvaia Breakdown of academic impact, for papers by Brian P. Adley Breakdown of academic impact, for papers by Jia-Lin Lee Breakdown of academic impact, for papers by Marco Pizzi Breakdown of academic impact, for papers by Yuji Sakuma Breakdown of academic impact, for papers by Thomas A. Puchalski Breakdown of academic impact, for papers by Hee Eun Lee Breakdown of academic impact, for papers by Laura Boldrini
Rankless by CCL
2026